Loading…
Telomir Pharmaceuticals, Inc. is projected to rise to $1.35 by 2027, a +10% move from its current price of $1.23. TELO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.19 | $1.23 | $1.27 | -0.02% |
| Jul 14 | $1.18 | $1.23 | $1.28 | -0.04% |
| Jul 15 | $1.17 | $1.23 | $1.29 | -0.06% |
| Jul 16 | $1.16 | $1.23 | $1.30 | -0.08% |
| Jul 17 | $1.15 | $1.23 | $1.31 | -0.09% |
| Jul 18 | $1.14 | $1.23 | $1.32 | -0.11% |
| Jul 19 | $1.14 | $1.23 | $1.33 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.14 | $1.23 | $1.33 | -0.13% |
| Week 2 | $1.10 | $1.23 | $1.37 | -0.26% |
| Week 3 | $1.07 | $1.23 | $1.40 | -0.39% |
| Week 4 | $1.04 | $1.22 | $1.43 | -0.53% |
| Week 5 | $1.02 | $1.22 | $1.46 | -0.66% |
| Week 6 | $1.01 | $1.22 | $1.48 | -0.79% |
| Week 7 | $0.989 | $1.22 | $1.50 | -0.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Telomir Pharmaceuticals, Inc. (TELO) is described as a healthcare company operating in the biotechnology space with a preclinical-stage focus. It concentrates on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases.
Telomir Pharmaceuticals, Inc. trades at a current price of $1.28 and has a market capitalization of $88.03M. It is ranked 4028 by market cap among peers.
A major floor 12.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 15.4% above — a clean break opens room to run.
A major ceiling 21.7% above — clearing it would confirm fresh momentum.
Key TELO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TELO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.25 | Sell | $1.25 | Sell |
| MA 10 | $1.26 | Sell | $1.26 | Sell |
| MA 20 | $1.27 | Sell | $1.26 | Sell |
| MA 50 | $1.28 | Sell | $1.28 | Sell |
| MA 100 | $1.29 | Sell | $1.30 | Sell |
| MA 200 | $1.34 | Sell | $1.49 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.56 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -95.98 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -1.60 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 33.01 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 1.24 | Sell |
| ADX (14) | 6.40 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture shows NEUTRAL sentiment with a 14-day RSI of 50. The stock’s short-term moving averages sit at $1.31 (SMA50) and $1.35 (SMA200). Support is at $1.19 and resistance at $1.42. The 30-day price range runs from $0.9769 to $1.68, and annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.08 | $1.23 | $1.55 | 0% | Neutral | |
| $1.07 | $1.35 | $1.82 | +10% | Neutral | |
| $1.15 | $1.50 | $2.10 | +22% | Bullish | |
| $1.27 | $1.70 | $2.45 | +38% | Bullish | |
| $1.35 | $1.85 | $2.74 | +51% | Bullish | |
| $1.23 | $1.73 | $2.62 | +40% | Bullish | |
| $1.23 | $1.76 | $2.72 | +43% | Bullish | |
| $1.28 | $1.86 | $2.94 | +52% | Bullish | |
| $1.42 | $2.10 | $3.37 | +71% | Bullish | |
| $1.71 | $2.57 | $4.19 | +109% | Bullish | |
| $1.83 | $2.97 | $5.16 | +141% | Bullish | |
| $2.76 | $5.10 | $9.76 | +315% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.08 | $1.23 | $1.42 | +0.00% |
| August 2026 | $1.01 | $1.19 | $1.45 | -2.99% |
| September 2026 | $1.01 | $1.21 | $1.49 | +1.33% |
| October 2026 | $0.9787 | $1.17 | $1.46 | -2.85% |
| November 2026 | $0.9687 | $1.17 | $1.47 | -0.46% |
| December 2026 | $1.01 | $1.23 | $1.55 | +4.82% |
Click any year to see its month-by-month TELO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, TELO could reach as high as $1.55, with a base case around $1.23 and support toward $1.08 — roughly 0% from $1.23. A consolidation phase looks the most probable path here.
Expect TELO to range from $1.07 to $1.82 through 2027. The $1.35 average target implies a +10% move from current prices. That is up +10% on the projected 2026 average. Price action looks broadly range-bound.
The TELO price prediction for 2028 points to an average of $1.50 (low $1.15, high $2.10) — a potential gain of +22% on today's $1.23. Buyers look set to stay in control over this stretch.
In 2029, TELO is projected to trade between $1.27 and $2.45, averaging $1.70 — a potential gain of +38% from today's $1.23. That is up +13% on the projected 2028 average. Momentum favours further upside here.
Telomir Pharmaceuticals, Inc.'s 2030 outlook centres on $1.85, within a $1.35 to $2.74 range. That is up +9% on the projected 2029 average. That marks a +51% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, TELO could reach as high as $2.62, with a base case around $1.73 and support toward $1.23 — roughly +40% from $1.23. Momentum favours further upside here.
Expect TELO to range from $1.23 to $2.72 through 2032. The $1.76 average target implies a +43% move from current prices. That is up +2% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The TELO price prediction for 2033 points to an average of $1.86 (low $1.28, high $2.94) — a potential gain of +52% on today's $1.23. Momentum favours further upside here.
In 2034, TELO is projected to trade between $1.42 and $3.37, averaging $2.10 — a potential gain of +71% from today's $1.23. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Telomir Pharmaceuticals, Inc.'s 2035 outlook centres on $2.57, within a $1.71 to $4.19 range. That is up +22% on the projected 2034 average. That marks a +109% change versus current levels. Momentum favours further upside here.
By 2040, TELO could reach as high as $5.16, with a base case around $2.97 and support toward $1.83 — roughly +141% from $1.23. Buyers look set to stay in control over this stretch.
Expect TELO to range from $2.76 to $9.76 through 2050. The $5.10 average target implies a +315% move from current prices. That is up +72% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TELO today (≈ 813.00813 TELO) could be worth
$4,149.92
+$3,149.92 (+315%) by 2050 · US Dollar
Based on the average projected TELO price of $5.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TELOwould be worth at today's price.
$1,000 invested in TELO on Jul 10, 2025 (≈ 854.700886 TELO) would be worth
$1,051.28
+$51.28 (+5.1%) today · 1.05× · US Dollar
Based on a TELO entry price of $1.17 vs. today's $1.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.27 | $968.5 | -3.1% |
| 1 month ago | $1.24 | $991.94 | -0.8% |
| 3 months ago | $1.22 | $1,008.2 | +0.8% |
| 6 months ago | $1.35 | $911.11 | -8.9% |
| 1 year ago | $1.17 | $1,051.28 | +5.1% |
| All time (2.4y) ago | $5 | $246 | -75.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TELO forecast.
Our base-case forecast reaches $2.50 around 2035.
Implied market cap at $2.50: $171.94M
Forecasts indicate a bullish trajectory beyond 2027, with NEUTRAL sentiment in 2026 and 2027, then a transition to BULLISH from 2028 onward. The path shows rising average prices: 2026 avg $1.28; 2027 avg $1.38; 2028 avg $1.69; 2029 avg $1.91; 2030 avg $2.03; 2031 avg $1.89; 2032 avg $1.84; 2033 avg $1.97; 2034 avg $2.42; 2035 avg $2.96; 2040 avg $3.37; 2050 avg $5.60. Corresponding ROIs become progressively larger, culminating in 2050 with ROI 337.9%.
These figures reflect estimates, not guarantees, and are subject to market and clinical developments.
Tap a question to reveal the answer.
The forecast shows an average price of $1.38 with an estimated ROI of 7.6% (sentiment NEUTRAL).
The forecast points to a bullish path from 2028 onward, with increasing average prices (e.g., $1.69 in 2028, rising to $5.60 by 2050) and higher ROIs (up to 337.9% in 2050). These are estimates, not guarantees.
The 2035 maximum price is $5.34, with an average of $2.96, suggesting that reaching around $5 is within the forecasted maximum there.
The 2040 forecast shows an average price of $3.37 with a maximum of $6.59 and ROI of 163.3%.
Current price is $1.28 and market cap is $88.03M.
Telomir Pharmaceuticals, Inc. Community Discussion
0Share your Telomir Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.